The short version
7 companies supply this market — a reasonable cushion if one runs into trouble. The generic price has held steady around $9.28 per unit over the past year.
Market view
etravirine · Tablet
16 marketed package NDCs · 7 active manufacturers
Most dispensed: 200 mg · Tablet · #60 tablets/bottle, plastic · 100 mg · Tablet · #120 tablets/bottle, plastic · 100 mg · Tablet · #120 tablets/bottle · 200 mg · Tablet · #60 tablets/bottle
Price range and competition
RSS: changes for this drugpriced separately — they are not the same market
Generic products only. Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Sep 2026 — typical price $9.28 · middle half $7.77–$10.79 · full range $7.77–$10.79 · 6 products · 7 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for etravirine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- etravirineAug 19, 2026Price downNADAC $11.24271 → $10.78853 per unit (-4.04%)
- EtravirineAug 19, 2026Price downNADAC $11.24271 → $10.78853 per unit (-4.04%)
- etravirineAug 19, 2026Price downNADAC $11.24271 → $10.78853 per unit (-4.04%)
- EtravirineAug 19, 2026Price downNADAC $11.24271 → $10.78853 per unit (-4.04%)
- EtravirineJul 22, 2026Price downNADAC $11.4115 → $11.24271 per unit (-1.48%)
- etravirineJul 22, 2026Price downNADAC $11.4115 → $11.24271 per unit (-1.48%)
- EtravirineJul 22, 2026Price downNADAC $11.4115 → $11.24271 per unit (-1.48%)
- etravirineJul 22, 2026Price downNADAC $11.4115 → $11.24271 per unit (-1.48%)
Same drug class
Other molecules FDA puts in Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- doravirine, islatravir· 1 maker
- emtricitabine, rilpivirine and tenofovir disoproxil fumarate· 1 maker
- emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide· 1 maker
- emtricitabine, rilpivirine, tenofovir disoproxil fumarate· 1 maker
- dolutegravir sodium and rilpivirine hydrochloride· 2 makers
- doravirine, lamivudine, and tenofovir disoproxil fumarate· 2 makers
- efavirenz, lamivudine and tenofovir disoproxil fumarate· 2 makers
- emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate· 2 makers
- doravirine· 5 makers
- efavirenz, emtricitabine and tenofovir disoproxil fumarate· 7 makers
- rilpivirine· 7 makers
- rilpivirine hydrochloride· 8 makers
Common questions
- Is Etravirine in shortage right now?
- No. FDA does not currently list Etravirine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Etravirine?
- 11 companies have marketed Etravirine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Etravirine cost?
- The typical pharmacy pays about $10.79 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
Shortage reports for this molecule
- Planned discontinuation — Etravirine, Tablet, 100 mg (NDC 10147-0570-1)Apr 28, 2026
- Planned discontinuation — Intelence, Tablet, 100 mg (NDC 59676-570-01)Apr 28, 2026
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.